Lab on chip based self-adjustable liposomes for rapid wound healing: An in depth in vitro, in vivo and higher dose toxicity investigation

Thanks to microfluidic technology, different nano -delivery systems are becoming clinically viable. Using a novel and rapid microfluidic hydrodynamic focusing (MHF) method (lipids on chip) we developed self -adaptable liposomes (SLs) containing cefpodoxime proxetil (CP) for the treatment of skin infections caused by Staphylococcus aureus. SLs were optimized using different flow rate ratios in the MHF method and the final formulation CPT3 was found to be the best in terms of particle size (68.27 +/- 01.15 nm), % entrapment efficiency (% EE: 82 +/- 1.5), polydispersity (PDI: 0.2 +/- 0.012), and degree of deformability (DOD: 4.7 +/- 0.18 nm). Rats (Sprague Dawley) treated with a self -adaptable CPT3 liposomal formulation recuperate skin injury, exhibited reduced bacterial counts (<10(6) CFU/mL) in the wounded region, and completely restored (100 %) on day 21. Rat survival, in vivo dermal pharmacokinetics and ex vivo -in vivo relationship were also investigated. Rats treated with an even 10fold higher dose (100 mg/kg/day) of CP using an equivalent CPT3 formulation did not show any symptoms of toxicity as revealed by hematological, biochemical, and internal organ assessment observations. Finally, the developed CPT3 formulation with special interest in patients with high -risk skin injuries not only delivered CP in a controlled manner but was also clinically effective and safe as it did not produce any serious adverse events even at 10x higher doses in the infected rats.